15 minutes delayed
Veradigm
MDRXOTCEM
Veradigm (OTC:MDRX) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/28/2024 | MDRX | Veradigm | FY | 2024 | — | — | — | $620.00M | $635.00M | — | Get Alert |
| 01/10/2024 | MDRX | Veradigm | FY | 2023 | $0.79 | $0.88 | $0.89 | $608.00M | $622.00M | $637.67M | Get Alert |
| 09/18/2023 | MDRX | Veradigm | FY | 2023 | $0.80 | $0.90 | $0.87 | $615.00M | $635.00M | $638.08M | Get Alert |
| 03/22/2023 | MDRX | Veradigm | FY | 2023 | $0.80 | $0.90 | $0.90 | $615.00M | $635.00M | $649.05M | Get Alert |
| 01/11/2023 | MDRX | Veradigm | FY | 2023 | $0.90 | $1.00 | $0.95 | $640.00M | $660.00M | $656.84M | Get Alert |
| 05/05/2022 | MDRX | Veradigm | FY | 2022 | — | — | — | $1.52B | $1.53B | $1.53B | Get Alert |
| 02/24/2022 | MDRX | Veradigm | FY | 2022 | — | — | — | $1.52B | $1.53B | $1.53B | Get Alert |
| 01/24/2022 | MDRX | Veradigm | Q4 | 2021 | — | — | — | $390.00M | $395.00M | $386.75M | Get Alert |
| 11/04/2021 | MDRX | Allscripts Healthcare | FY | 2021 | — | — | — | $1.50B | $1.50B | $1.50B | Get Alert |
| 08/05/2021 | MDRX | Allscripts Healthcare | FY | 2021 | — | — | — | $1.50B | $1.50B | $1.50B | Get Alert |
| 04/29/2021 | MDRX | Allscripts Healthcare | FY | 2021 | — | — | — | $1.50B | $1.50B | $1.50B | Get Alert |
| 02/25/2021 | MDRX | Allscripts Healthcare | FY | 2021 | — | — | — | $1.50B | $1.50B | $1.56B | Get Alert |
| 03/02/2020 | MDRX | Veradigm | FY | 2020 | $0.70 | $0.75 | $0.76 | $1.75B | $1.85B | $1.84B | Get Alert |
| 03/02/2020 | MDRX | Veradigm | Q1 | 2020 | — | — | — | $420.00M | $430.00M | $450.84M | Get Alert |
| 01/14/2020 | MDRX | Veradigm | Q4 | 2019 | — | — | — | $450.00M | $455.00M | $463.08M | Get Alert |
| 11/04/2019 | MDRX | Veradigm | FY | 2019 | $0.67 | $0.70 | $0.68 | — | — | — | Get Alert |
| 11/04/2019 | MDRX | Veradigm | Q4 | 2019 | — | — | — | $460.00M | $470.00M | $462.74M | Get Alert |
FAQ
What is the most recent guidance for Veradigm (MDRX)?
The last reported Earnings numbers were from January 10, 2024 for the full year 2023 and was for an earnings per share guidance in the range of $0.79 and $0.88 versus the estimated EPS of $0.89.
Browse guidance and forecast on all stocks.